Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 2591 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Search Again
 Table of Contents
 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Article Access Statistics
 Reader Comments
 Email Alert
 Add to My List
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded157    
    Comments [Add]    

Recommend this journal

Year : 2003  |  Volume : 45  |  Issue : 1  |  Page : 21-25

Electroconvulsive Therapy in Lorazepam Non-Responsive Catatonia

Senior Resident, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore-560029, India

Correspondence Address:
K Girish
Senior Resident, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore-560029
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 21206808

Rights and PermissionsRights and Permissions

Aim: Tb compare the efficacy of electroconvulsive therapy (ECT) with risperidone in the treatment of lorazepam non-responsive catatonia. Materials and methods: Inpatients with non-affective catatonia (n= 18) non-responsive to at least five-day trial of lorazepam (6-8 mg/day) were randomised into two groups in a double blind randomised design. Written informed consent was obtained. Four were dropped from the trial as they were found to have depressive catatonia. One group received true ECT (thrice weekly, n=8) plus oral placebo while the other received sham ECT plus risperidone (4-6 mg/ day). Bush-Francis Catatonia Rating Scale (BFCRS) was administered twice weekly to assess improvement in catatonic symptoms over a period of three weeks. The two groups were compared using two-way RMANOVA. Results: BFCRS scores reduced markedly over treatment course and this reduction was more profound in the ECT group (p=0.035). Shorter the duration of illness greater was the response (lower scores of BFCRS). Conclusions: Superior clinical efficacy of ECT over neuroleptics in catatonia is confirmed by this randomized clinical trial.



Print this article         Email this article